Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EYE NASDAQ:IRMD NASDAQ:LIVN NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYENational Vision$25.09-1.0%$21.71$9.56▼$25.52$2.00B1.271.90 million shs1.83 million shsIRMDiRadimed$57.45-0.8%$57.52$42.34▼$63.29$736.33M0.9144,118 shs28,100 shsLIVNLivaNova$42.54-1.0%$44.81$32.48▼$57.35$2.34B0.9627,642 shs577,377 shsWRBYWarby Parker$23.45+2.4%$21.07$12.46▼$28.68$2.39B2.092.00 million shs1.80 million shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYENational Vision-0.99%+2.24%+12.21%+115.00%+77.06%IRMDiRadimed-0.79%-3.40%-0.91%+10.97%+24.40%LIVNLivaNova-1.05%-8.85%-4.08%+19.56%-21.82%WRBYWarby Parker+2.42%+5.53%+7.34%+64.57%+41.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEYENational Vision2.8744 of 5 stars2.32.00.03.33.40.80.0IRMDiRadimed4.7447 of 5 stars2.53.02.54.42.73.31.9LIVNLivaNova3.1177 of 5 stars3.54.00.00.01.71.71.3WRBYWarby Parker2.4768 of 5 stars2.35.00.00.01.73.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEYENational Vision 2.56Moderate Buy$22.10-11.92% DownsideIRMDiRadimed 3.00Buy$72.0025.33% UpsideLIVNLivaNova 3.00Buy$59.2939.36% UpsideWRBYWarby Parker 2.53Moderate Buy$22.88-2.46% DownsideCurrent Analyst Ratings BreakdownLatest IRMD, WRBY, LIVN, and EYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/10/2025WRBYWarby ParkerJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Perform7/10/2025WRBYWarby ParkerCitizens JmpSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform7/8/2025EYENational VisionUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$30.007/8/2025EYENational VisionNational BanksharesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$30.007/8/2025EYENational VisionBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$17.00 ➝ $30.006/18/2025EYENational VisionBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$22.00 ➝ $26.005/29/2025WRBYWarby ParkerPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$20.00 ➝ $25.005/22/2025WRBYWarby ParkerRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$18.00 ➝ $21.005/21/2025WRBYWarby ParkerCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/21/2025WRBYWarby ParkerLoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/21/2025WRBYWarby ParkerCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$17.00 ➝ $22.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEYENational Vision$1.82B1.09$1.62 per share15.49$10.37 per share2.42IRMDiRadimed$73.24M9.98$1.57 per share36.60$6.85 per share8.39LIVNLivaNova$1.25B1.85$4.20 per share10.14$24.31 per share1.75WRBYWarby Parker$771.32M3.18$0.35 per share67.46$3.35 per share7.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEYENational Vision-$28.50M-$0.33N/A92.933.72-1.40%3.44%1.40%8/6/2025 (Estimated)IRMDiRadimed$19.23M$1.5537.0628.73N/A26.33%23.28%20.59%7/30/2025 (Estimated)LIVNLivaNova$63.23M-$4.09N/A13.55N/A-17.41%13.67%6.68%7/30/2025 (Estimated)WRBYWarby Parker-$20.39M-$0.12N/A234.53N/A-1.79%-2.48%-1.29%8/7/2025 (Confirmed)Latest IRMD, WRBY, LIVN, and EYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025WRBYWarby Parker$0.09N/AN/AN/AN/AN/A8/7/2025Q2 2025IRMDiRadimed$0.45N/AN/AN/AN/AN/A8/6/2025Q2 2025EYENational Vision$0.12N/AN/AN/A$469.21 millionN/A7/30/2025Q2 2025LIVNLivaNova$0.84N/AN/AN/A$332.20 millionN/A5/7/2025Q1 2025EYENational Vision$0.32$0.34+$0.02$0.18$510.30 million$510.32 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEYENational VisionN/AN/AN/AN/AN/AIRMDiRadimed$0.681.18%N/A43.87%1 YearsLIVNLivaNovaN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ALatest IRMD, WRBY, LIVN, and EYE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025IRMDiRadimedquarterly$0.171.3%5/20/20255/20/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEYENational Vision0.290.540.35IRMDiRadimedN/A8.877.62LIVNLivaNova0.531.581.37WRBYWarby ParkerN/A2.702.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEYENational VisionN/AIRMDiRadimed92.34%LIVNLivaNova97.64%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipEYENational Vision2.70%IRMDiRadimed36.80%LIVNLivaNova0.29%WRBYWarby Parker18.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEYENational Vision13,41179.05 million76.92 millionOptionableIRMDiRadimed11012.72 million8.04 millionOptionableLIVNLivaNova2,90054.53 million54.37 millionOptionableWRBYWarby Parker3,780104.50 million85.44 millionOptionableIRMD, WRBY, LIVN, and EYE HeadlinesRecent News About These CompaniesWarby Parker to Announce Second Quarter 2025 Financial Results August 7, 2025July 17 at 4:05 PM | businesswire.comCenterBook Partners LP Invests $1.42 Million in Warby Parker Inc. (NYSE:WRBY)July 17 at 9:54 AM | marketbeat.comHead to Head Comparison: Warby Parker (WRBY) & Its RivalsJuly 17 at 4:03 AM | americanbankingnews.comWarby Parker Inc. (NYSE:WRBY) Shares Bought by Bank of New York Mellon CorpJuly 16 at 3:39 AM | marketbeat.comWarby Parker (NYSE:WRBY) Stock Price Up 5.9% - Here's WhyJuly 14, 2025 | marketbeat.comWarby Parker Inc. (NYSE:WRBY) Shares Sold by TimesSquare Capital Management LLCJuly 14, 2025 | marketbeat.comContrasting Warby Parker (WRBY) & The CompetitionJuly 14, 2025 | americanbankingnews.comWarby Parker (NYSE:WRBY) Cut to Market Perform at Citizens JmpJuly 13, 2025 | americanbankingnews.comWarby Parker's (WRBY) Market Perform Rating Reiterated at JMP SecuritiesJuly 13, 2025 | americanbankingnews.comJMP Securities Downgrades Warby Parker (WRBY)July 11, 2025 | msn.comWarby Parker (NYSE:WRBY) Receives "Market Perform" Rating from JMP SecuritiesJuly 10, 2025 | marketbeat.comWarby Parker (NYSE:WRBY) Stock Rating Lowered by Citizens JmpJuly 10, 2025 | marketbeat.comWarby Parker Inc. Stock Grades | WRBY - Barron'sJuly 10, 2025 | barrons.comWarby Parker Inc. (NYSE:WRBY) Receives $22.88 Average PT from AnalystsJuly 9, 2025 | americanbankingnews.comWinners And Losers Of Q1: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer StocksJuly 8, 2025 | msn.comWarby Parker Inc. (NYSE:WRBY) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 6, 2025 | marketbeat.com11,751 Shares in Warby Parker Inc. (NYSE:WRBY) Acquired by Diversified Trust CoJuly 2, 2025 | marketbeat.comWhat Makes Warby Parker (WRBY) an Attractive Investment?June 30, 2025 | finance.yahoo.comBessemer Group Inc. Has $1.17 Million Stock Position in Warby Parker Inc. (NYSE:WRBY)June 30, 2025 | marketbeat.comWRBY - Warby Parker Inc Ordinary Shares - Class A Chart - MorningstarJune 28, 2025 | morningstar.comMThe 5 Most Interesting Analyst Questions From Warby Parker’s Q1 Earnings CallJune 27, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIRMD, WRBY, LIVN, and EYE Company DescriptionsNational Vision NASDAQ:EYE$25.09 -0.25 (-0.99%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$25.23 +0.14 (+0.55%) As of 08:50 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.iRadimed NASDAQ:IRMD$57.45 -0.46 (-0.79%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$57.44 -0.01 (-0.02%) As of 07/17/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.LivaNova NASDAQ:LIVN$42.54 -0.45 (-1.05%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$42.54 +0.01 (+0.01%) As of 07/17/2025 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.Warby Parker NYSE:WRBY$23.45 +0.55 (+2.41%) Closing price 07/17/2025 03:59 PM EasternExtended Trading$23.79 +0.34 (+1.45%) As of 09:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate How Goldman Sachs Earnings Help You Strategize Your Portfolio Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
